T2 Biosystems, Inc. (TTOO)
OTCMKTS · Delayed Price · Currency is USD
0.0121
-0.0029 (-19.33%)
At close: Nov 28, 2025
T2 Biosystems Market Cap
T2 Biosystems has a market cap or net worth of $339.35 thousand as of November 28, 2025. Its market cap has decreased by -97.57% in one year.
Market Cap
339.35K
Enterprise Value
17.20M
Revenue
7.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since August 7, 2014, T2 Biosystems's market cap has decreased from 274.87M to 339.35K, a decrease of -99.88%. That is a compound annual growth rate of -44.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 339.35K | -96.16% |
| Dec 31, 2024 | 8.84M | -65.23% |
| Dec 29, 2023 | 25.42M | 144.54% |
| Dec 30, 2022 | 10.39M | -87.87% |
| Dec 31, 2021 | 85.67M | -53.30% |
| Dec 31, 2020 | 183.46M | 235.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 849.79M |
| Elite Pharmaceuticals | 571.69M |
| Glass House Brands | 486.41M |
| American Oncology Network | 429.20M |
| CytoDyn | 414.34M |
| Northwest Biotherapeutics | 394.75M |
| Silence Therapeutics | 318.36M |
| Nika Pharmaceuticals | 259.96M |